RAPT Therapeutics effects 1-for-8 reverse stock split; post-split shares ~16.5M

RAPT Therapeutics, Inc.

Stockholders approved reverse split at May 29, 2025 annual meeting.
Effective June 16, 2025, RAPT effected a 1-for-8 reverse stock split.
Post-split shares outstanding approx. 16.5 million (before eliminating fractional shares).
Certificate of Amendment filed with Delaware on June 13, 2025.

item 5.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.